The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant chemotherapy with atezolizumab, bevacizumab, and FOLFOX for patients with unresectable colorectal liver metastases: A translational pilot study.
 
Sun Young Kim
Honoraria - Boryung; LG Chem; Merck
Consulting or Advisory Role - Guardant Health; Ono Pharmaceutical
Research Funding - Roche/Genentech (Inst)
Expert Testimony - Guardant Health
 
Wonkyung Kim
No Relationships to Disclose
 
Chang Ohk Sung
No Relationships to Disclose
 
Jihun Kim
No Relationships to Disclose
 
Yong Sang Hong
No Relationships to Disclose
 
Jeong Eun Kim
Consulting or Advisory Role - Roche/Genentech
 
Tae Won Kim
Employment - Asan Medical Center
Research Funding - Genome Insight (Inst); Roche/Genentech (Inst)